FORMULARY WATCH

ADHD

TODAY'S HEADLINES

FDA approves chewable pill for pediatric ADHD

FDA has approved methylphenidate hydrochloride (QuilliChew ER, Pfizer) extended-release chewable tablets for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children. Read more

FDA approves the first recombinant von Willebrand factor

FDA has approved recombinant von Willebrand factor (Vonvendi, Baxalta) for use in adult patients who have von Willebrand disease. Read more

CONTINUING PHARMACY EDUCATION

MTM essentials for cough management

Pharmacists can help patients with the various management options for the most common causes of cough. More

5 things to know about the new seasonal flu vaccine

Here are 5 facts you should know about the first seasonal influenza vaccine containing an adjuvant. Details

December 18, 2015

Adults surpass kids for ADHD scripts

FDA approves orphan drug for bleeding disorder

Click to contact the editorial team. Click to contact the sales team.

Part of the

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply.
Please use the links provided if you have questions or concerns regarding this email or your subscription.

This email was sent by: %%Member_Busname%%
%%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%

NEWSLETTER

Forward to a Friend
Privacy Statement
Terms of Service
Update Profile
Add/Remove Newsletters
Contact Us